Doctors Note Logo

Published on: 6/14/2026

Dry Eye Syndrome: What Doctors Now Understand About the Inflammation Behind It

Chronic inflammation is now recognized as both a cause and consequence of dry eye disease, creating a self-perpetuating cycle that disrupts tear production, damages the ocular surface, and destabilizes the tear film. Lasting relief requires more than artificial tears. Modern treatment combines anti-inflammatory therapies, meibomian gland treatments, and targeted lifestyle adjustments customized to your specific dry eye subtype.

Understanding your triggers, symptoms, diagnostic options, and access to cutting-edge therapies is essential to breaking the cycle. Because dry eye symptoms often overlap with other ocular and systemic conditions, identifying the root cause early can dramatically improve outcomes. Before scheduling appointments or trying new treatments, take a free, instant, online symptom check to clarify what may be driving your discomfort and confidently plan your next healthcare steps.

Reviewed for medical accuracy: 06/14/2026

answer background

Explanation

Dry Eye Syndrome: What Doctors Now Understand About the Inflammation Behind It

Dry eye syndrome is one of the most common eye complaints worldwide, affecting millions of people. Once thought to be a simple lack of tears, doctors now recognize a complex interplay of factors—particularly chronic inflammation—that damage the eye's surface and tear film. Understanding this inflammation is key to more effective treatments and long-term relief.

What Is Dry Eye Syndrome?

Dry eye syndrome occurs when your eyes can't produce enough quality tears or when they evaporate too quickly. Tears consist of three layers (oil, water, mucus) that keep the surface of your eye smooth, clear, and protected from infection. When any layer is compromised—often due to inflammation—the result is dry, irritated eyes.

Key points:

  • Reduced tear production or increased tear evaporation
  • Tear-film instability leading to ocular surface damage
  • Two main types:
    • Aqueous-deficient (not enough tear fluid)
    • Evaporative (oil-layer deficiency)

The Role of Inflammation

Recent research shows that chronic, low-grade inflammation plays a central role in dry eye syndrome. Rather than being just a symptom, inflammation can be a driver of tear-film instability and ocular surface damage.

How inflammation develops:

  • Trigger (environment, digital screens, contact lenses) injures the tear film or eyelid glands
  • Immune cells release inflammatory molecules (cytokines, chemokines)
  • Tear glands and eyelid margins become dysregulated
  • A vicious cycle: inflammation causes more tear-film damage, which in turn fuels more inflammation

Common Triggers and Risk Factors

While inflammation is the underlying mechanism, many factors can start the cascade:

  • Environmental: dry climates, wind, smoke, air conditioning
  • Digital eye strain: prolonged screen use reduces blink rate
  • Age and hormonal changes: menopause, aging decrease tear production
  • Medications: antihistamines, antidepressants, blood pressure drugs
  • Health conditions: autoimmune diseases (e.g., rheumatoid arthritis), diabetes
  • Eyelid issues: blepharitis, meibomian gland dysfunction

Recognizing the Symptoms

Symptoms can range from mild discomfort to significant vision disturbance. Common signs include:

  • Burning, stinging, or gritty sensation
  • Redness or blurred vision
  • Excessive tearing (reflex tearing)
  • Light sensitivity or eye fatigue
  • Stringy mucus around the eyes

If you're experiencing any of these symptoms and want to better understand what might be causing them, Ubie's free AI-powered Dry eye symptom checker can help you identify potential issues and recommend your next steps.

How Doctors Diagnose Dry Eye Syndrome

A thorough eye exam typically includes:

  • Patient history: symptom patterns, medication review
  • Tear-film tests: Schirmer's test (tear quantity), tear breakup time (stability)
  • Ocular surface staining: special dyes (fluorescein, lissamine green) to highlight damage
  • Eyelid and gland evaluation: checking for inflammation or blockage

These tests help determine whether inflammation is driving your dry eye syndrome and guide treatment choices.

Anti-Inflammatory Treatments

Targeting inflammation directly can break the vicious cycle of dry eye. Common approaches include:

  • Topical cyclosporine (Restasis®): reduces immune-mediated inflammation in tear glands
  • Lifitegrast (Xiidra®): blocks inflammatory cell activation on the ocular surface
  • Short-term corticosteroids: for flare-ups, used under close supervision
  • Omega-3 supplements: may help reduce inflammation in the tear glands
  • Tetracycline antibiotics: low-dose doxycycline or minocycline for meibomian gland dysfunction

Your doctor will tailor these treatments based on severity, underlying causes, and response to therapy.

Tear Substitutes and Supportive Measures

While anti-inflammatory drugs address the root cause, symptom relief often requires tear support:

  • Artificial tears: preservative-free drops used multiple times daily
  • Gels or ointments: thicker, longer-lasting lubrication for nighttime use
  • Punctal plugs: tiny devices inserted into tear ducts to conserve your natural tears
  • Moisture chambers: wraparound goggles or humidifiers to decrease tear evaporation

Combining tear substitutes with anti-inflammatory therapy often yields the best results.

Lifestyle and At-Home Strategies

Small changes in daily habits can reduce inflammation triggers and improve tear-film health:

  • Blink more often, especially during screen use
  • Take regular screen breaks (20-20-20 rule: every 20 minutes, look at something 20 feet away for 20 seconds)
  • Use a humidifier in dry environments
  • Avoid direct air flow from fans or vents
  • Practice good eyelid hygiene: warm compresses and gentle lid massage to clear blocked glands
  • Stay hydrated and eat a balanced diet rich in omega-3 fatty acids

Emerging Therapies and Research

Doctors continue to explore innovative approaches to manage inflammation in dry eye syndrome:

  • Biologics: targeted antibodies against specific inflammatory cytokines
  • Novel small molecules: designed to interrupt inflammatory pathways on the ocular surface
  • Regenerative medicine: stem-cell therapies to repair tear glands and eyelid tissues
  • Drug-eluting contact lenses: controlled delivery of anti-inflammatory agents

While still under investigation, these therapies hold promise for patients who don't respond to current treatments.

When to See a Doctor

Although dry eye syndrome is rarely life-threatening, severe or sudden changes in vision, intense pain, or signs of infection (excessive redness, discharge) warrant prompt medical attention. Always:

  • Follow your eye doctor's treatment plan
  • Report new or worsening symptoms
  • Attend regular follow-up visits to monitor inflammation and adjust therapy

If you experience severe eye pain or vision loss, seek immediate medical care.


Dry eye syndrome is more than just an occasional irritation—it's often a chronic inflammatory condition that requires targeted treatment. By understanding the role of inflammation and combining medical therapies with lifestyle adjustments, most people can achieve significant relief. If you're concerned about your symptoms, take a moment to complete Ubie's free Dry eye symptom checker for personalized insights before speaking to a doctor about the best approach for you. Always consult your eye care professional for personalized advice and to rule out any serious underlying conditions.

(References)

  • * Gao J, Wu S, Zhang H, Han B, Sun Y, Wang Y. The Ocular Surface Inflammatory Cycle: From Pathogenesis to Therapeutic Strategies. Int J Mol Sci. 2023 Feb 15;24(4):3812. doi: 10.3390/ijms24043812. PMID: 36835267; PMCID: PMC9995167.

  • * Zaydun M, Al-Badaineh MA, Al-Shamma'a M, Aweidah A. Update on the Pathogenesis and Treatment of Dry Eye Syndrome. Biomedicines. 2023 Aug 18;11(8):2294. doi: 10.3390/biomedicines11082294. PMID: 37626727; PMCID: PMC10452936.

  • * Liguori L, Marotta C, Liguori G, Del Prete M, Liguori A, Liguori G. The Role of Inflammation in Dry Eye Disease: An Overview of the Current State of Knowledge and Future Perspectives. Diagnostics (Basel). 2024 Jan 15;14(2):168. doi: 10.3390/diagnostics14020168. PMID: 38250640; PMCID: PMC10815124.

  • * Ruzickova E, Slanar O, Sunkova V. Advances in Understanding and Management of Dry Eye Disease. Int J Mol Sci. 2022 Dec 17;23(24):16027. doi: 10.3390/ijms232416027. PMID: 36555776; PMCID: PMC9779344.

  • * Li M, Tang P, Li N, Fan Z, Chen R, Ma C, Wang W. Recent Advances in Immunological Mechanism and Immunotherapy in Dry Eye Disease. Cells. 2022 Jun 15;11(12):1914. doi: 10.3390/cells111201914. PMID: 35741031; PMCID: PMC9222378.

Thinking about asking ChatGPT?Ask me instead

Tell your friends about us.

We would love to help them too.

smily Shiba-inu looking

For First Time Users

What is Ubie’s Doctor’s Note?

We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.

Was this page helpful?

Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.